Effect of Conversion from ESA with Shorter Half-Life to CERA Once Monthly for Maintaining Hb Concentration in Pre-Dialysis CKD Patients

• Autors principals: Ji-Young Choi (Autor), Chul Woo Yang (Autor), Yeong-Hoon Kim (Autor), Kwon Wook Joo (Autor), Tae-Hyun Yoo (Autor), Kang Wook Lee (Autor), Sang-Ho Lee (Autor), Ju-Young Moon (Autor), Sug Kyun Shin (Autor), Wooseong Huh (Autor), Nam-Ho Kim (Autor), Sun-Hee Park (Autor), Chan-Duck Kim (Autor), Yong-Lim Kim (Autor)
• Format: Llibre
• Publicat: Karger Publishers, 2013-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: The purpose of this study is to identify whether hemoglobin (Hb) concentrations can be maintained, and to investigate changes in biomarkers, when switching from erythropoietin stimulating agents (ESA) with shorter half-life to once-monthly subcutaneous methoxy polyethylene glycol-epoetin...